Labor Is Manufacturing an NDIS Crisis to Justify Cuts - the Savings Will Be Spent on War
The Albanese Labor government has embarked on a coordinated campaign to shrink the National Disability Insurance Scheme (NDIS), stripping $14.4 billion in the 2024 budget and projecting $19 billion in savings over four years. A review commissioned in 2022 and a RedBridge‑led media strategy framed the cuts as a fraud‑prevention effort, yet only about 1 % of the projected savings target fraud. The reforms disproportionately target children with mild‑to‑moderate autism, leading to mass reassessments and funding withdrawals. Simultaneously, the government is gearing up to boost defense spending by $53 billion over the next decade, suggesting a fiscal trade‑off between disability support and military investment.
Rogan Tipped the Scales on Psychedelic Research in the US
Joe Rogan appeared at the White House as President Trump signed an executive order to fast‑track psychedelic research and clinical trials. The directive directs federal agencies to accelerate approval pathways for psychedelic therapeutics aimed at PTSD, veteran mental health, and...
What to Know Before Buying GLP-1 Drugs Online
The FDA warns that many online ads for GLP‑1 weight‑loss drugs promote compounded versions that lack the rigorous testing of brand‑name products like Ozempic, Wegovy, and Mounjaro. These compounded formulations can vary in concentration, contain unapproved ingredients, and have been...
How Artificial Intelligence Scales Physician Extension
Dr. Tod Stillson argues that the traditional physician‑extension model—relying on nurses, NPs, and PAs—can no longer meet the growing demand for primary care, especially in rural areas. He proposes a physician‑governed artificial‑intelligence platform that codifies clinical reasoning, protocols, and escalation...
Joe Rogan Reveals Trump IMMEDIATELY Offered Him FDA Approval for Unbelievable New Treatment...
President Donald Trump issued an executive order accelerating federal research on ibogaine, a Schedule I psychedelic, to create FDA pathways for veteran mental‑health treatment. The order follows claims that ibogaine can address depression, PTSD and substance abuse, with the FDA expected...
Dasatinib and Quercetin as Senolytic May Cause Brain Damage
A March 2026 PNAS study shows that the senolytic combo dasatinib and quercetin (D+Q) triggers demyelination in the corpus callosum of aged mice. The researchers used intermittent oral doses of 5 mg/kg dasatinib and 50 mg/kg quercetin, identical to regimens linked to...
Did the Old Way Ever Work?
In a recent talk, the author argues that the traditional deficit model—leading with data and facts—no longer works for public health communication in 2026. Trust in institutions has eroded, and the crowded information landscape makes simple fact sheets backfire, especially...
Bundles Are Back, Now Mandatory and Nationwide: A Builder’s Field Guide to the New Companies, Tools, and Channels That Should...
On April 10, CMS released the FY 2027 IPPS proposed rule, introducing CJR‑X—the first mandatory, nationwide, episode‑based payment model for lower‑extremity joint replacement. The model will start on October 1 2027, covering over 3,000 IPPS hospitals for five performance years and expanding the episode...
Surgical Robotics Beyond NVIDIA GTC
NVIDIA unveiled Open‑H, the largest open surgical‑robotics dataset with over 26,500 task demonstrations and nearly 5 million video‑motion frame pairs collected from nine robot platforms across more than ten institutions. Coupled with the Cosmos‑H world model, the company can generate photorealistic,...
Curing U.S. Health Care, Part I
The Affordable Care Act, enacted in 2010 and fully implemented by 2014, expanded coverage to millions of Americans and slowed the growth of national health‑spending. Yet by 2024, roughly 8% of the population remains uninsured, and a larger share is...
A Closer Look at Body Composition in Obesity Drug Trials
A new systematic review of 36 randomized controlled trials, published in Annals of Internal Medicine, reveals that obesity medications often cause a sizable loss of lean mass. In 65% of drug trials, more than a quarter of total weight loss...
Weekly Reads: Prasad Successor, Sammy Hagar Stem Cells, More on OSK Trial, Finnish Speaker Needed
Vinay Prasad is set to leave his role as head of the FDA's Center for Biologics Evaluation and Research (CBER within two weeks, prompting speculation about the agency’s future direction. A new flexible oversight framework for rare‑disease gene and cell therapies...
CMS Just Moved $13 Billion in Medicare Advantage Payments. Here's What Healthcare Investors Need to Know.
CMS announced a 2.48% Medicare Advantage rate increase for 2027, adding roughly $13 billion in federal payments. The agency also froze the risk‑adjustment model, reversing a proposed -3.32% recalibration that would have erased most growth. Simultaneously, CMS eliminated 11 Star Ratings...
The Next Chemical Cage Has a Beautiful Door
President Biden signed an executive order fast‑tracking psychedelic drugs, granting the FDA priority vouchers for serotonin‑2A agonists. The move follows a public ceremony with Joe Rogan, RFK Jr., and FDA Commissioner Marty Makary, signaling a shift from traditional plant‑based use to pharmaceutical...
CDC: Antibiotic Resistant Shigella Becoming Higher Risk in US
The CDC’s latest analysis shows a sharp rise in extensively drug‑resistant (XDR) Shigella infections in the United States, climbing from 0% of isolates in 2011‑2015 to 8.5% in 2023. Of the 510 XDR isolates identified, two‑thirds were Shigella sonnei and...
HSS Studies Contribute Early Evidence to Help Guide Emerging Perioperative Considerations for Patients Using GLP‑1 Medications
At the ASRA annual meeting, Hospital for Special Surgery researchers presented two studies on peri‑operative management of patients taking GLP‑1 agonists. A multicenter ultrasound assessment of 354 elective surgery patients found no statistically significant difference in full‑stomach incidence between GLP‑1...
Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments
Compass Pathways welcomed the White House Executive Order aimed at speeding up research and access to psychedelic therapies for serious mental illness. The biotech highlighted its COMP360 synthetic psilocybin, which has delivered statistically significant results in two Phase 3 trials for...
Fauci And CDC Proven Wrong As Massive Denmark Study Shows Masks And Vaccines Failed To Stop COVID
The blog post argues that masks and COVID‑19 vaccines failed to curb the pandemic, citing a large Danish study as evidence. It quotes Anthony Fauci and former CDC chief Rochelle Walensky asserting that vaccines, masks, tests and antivirals were the "tools"...
Why We Still Underestimate the Danger of Cigarettes
Cigarette smoking remains the leading preventable cause of death in the United States, killing roughly 480,000 people each year and costing about $240 billion in health‑care expenses. Although the adult smoking rate has fallen from 41 % in 1944 to 11 % in...
INSANITY IN CANADA: Depression and Eating Disorders Now Floated as Reasons for Assisted Death
Canada’s Special Joint Parliamentary Committee is debating whether to extend Medical Assistance in Dying (MAiD) to individuals with severe depression or eating disorders. Psychiatrist Dr. Mona Gupta told MPs the criteria could be met on a case‑by‑case basis, prompting fierce...
How Regulating Clinical Empathy Prevents Physician Burnout
The article argues that physicians burn out not from caring too much but from unregulated empathy that turns patients' stories into personal trauma. By distinguishing a patient’s story from their feelings, clinicians can practice regulated compassion, reducing emotional exhaustion. Research...
Group Pushes Ottawa to Ban Flavoured Vapes
Anti‑smoking groups and a University of Ottawa doctor are pressuring Health Minister Marjorie Michel to prohibit flavored vaping products nationwide. They cite a Health Canada study showing that 21% of the 300,000 Canadians who quit smoking in 2024 used vapes, while...
How CDC Opioid Guidelines Harmed Chronic Pain Patients
The 2016 CDC guideline for prescribing opioids was widely treated as a hard rule, prompting sharp cuts in legitimate prescriptions. While opioid dispensing fell over 52% since 2012, overdose deaths continued to climb, driven primarily by illicit fentanyl rather than...
Operational Inflection + GLP-1 Winner
A low‑priced consumer business currently in a turnaround is hitting an operational inflection point, with GLP‑1 drug adoption expected to accelerate growth. The company trades at roughly 4.7 × EBITDA and holds net cash equal to about half its market capitalization, creating...
Capitol Dispatch Weekend Digest
The Capitol Dispatch Weekend Digest reports several policy‑driven shifts affecting Connecticut and the nation. A Senate committee found that drug companies which secured pricing deals under the Trump administration later raised prices on unrelated medicines, while USDA data shows Connecticut’s...
Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation...
Zai Lab unveiled preclinical data for ZL-1503, a bispecific antibody that blocks IL-13 and IL-31Rα, showing sustained itch suppression and inflammation reduction for up to 112 days after a single dose. The study demonstrated dose‑dependent efficacy across skin, lung, nasal...
The Medicine Is Running Out. This Is What Abandonment Looks Like.
On April 1, the U.S. State Department ordered the Global Health Supply Chain program—running since 2016 and responsible for delivering more than $5 billion in HIV and malaria medicines to 90 countries—to shut down by May 30 with no transition plan....
The Hidden Risks of AI Documentation Tools in Clinical Practice
AI-powered ambient scribe tools are entering exam rooms, generating draft clinical notes while physicians see patients. Proponents cite reduced documentation burden and more patient‑focused time, but the technology can hallucinate details—adding false diagnoses or statements that never occurred. Because physicians...
How Credentialing and Culture Impact Physician Mental Health
Physician burnout and mental‑health stigma are intensifying as 46% of health workers report frequent exhaustion, costing the U.S. health system roughly $4.6 billion a year. Credentialing forms that probe mental‑health history and drug use create a privacy fear that discourages clinicians...
Why GLP-1 Medications Require Expert Nutrition Guidance
GLP‑1 medications are reshaping obesity and diabetes treatment by delivering significant weight loss, but their appetite‑suppressing effects can lead to protein shortfalls, vitamin gaps, and muscle loss. A recent Academy of Nutrition and Dietetics survey found 98% of professionals flag...
GPT-Rosalind Lands: What OpenAI’s First Domain-Specific Life Sciences Model, the Codex Life Sciences Plugin & the Trusted Access Program Actually...
OpenAI unveiled GPT‑Rosalind on April 16, its first domain‑specific model built for life‑sciences tasks such as biochemistry, genomics, and protein engineering. Access is limited to a Trusted‑Access program that currently includes Amgen, Moderna, Thermo Fisher Scientific, the Allen Institute and...
Why Current Solutions to Physician Burnout Are Failing
After a decade of wellness programs, physician burnout remains at 45% according to the AMA’s 2023 survey, essentially unchanged from earlier levels. Traditional solutions target environmental stressors—hours, bureaucracy, EHR—but the article argues this model fails because the harsh environment persists....
Prostate Cancer: A PSA on PSA
Prostate cancer mortality is stalling as advanced‑stage diagnoses climb in the United States and Canada, a trend linked to the 2008‑2012 USPSTF move away from routine PSA screening. New evidence shows that refined PSA strategies—tracking PSA velocity and PSA density—combined...
East Anglian Air Ambulance Launches £8.2m Appeal for New Cambridge Base as Airport Closure Looms
East Anglian Air Ambulance (EAAA) has launched an $10.5 million fundraising appeal to build a new base at New Shardelowes Farm near Fulbourn, as Cambridge City Airport faces closure in 2030. The charity currently operates two hubs, and losing the Cambridge...
The New Stack CMS Built While You Weren't Looking
CMS has unveiled a coordinated payment architecture that expands beyond traditional fee‑for‑service, launching the ACCESS model with over 150 approved participants slated to begin July 5. The model pays Medicare beneficiaries directly for outcome‑aligned chronic disease management, featuring consumer brands...
Real Risks & Theoretical Benefits of Drinking Raw Milk
The blog post warns that raw milk carries significant microbiological hazards, including Salmonella, Shiga‑toxin‑producing E. coli, Campylobacter, Listeria and parasites such as Cryptosporidium. Because it spoils quickly—within hours at room temperature and even faster in heat—raw milk must be collected under...
Deadly Delays and Treatment in Chains: How Prisons Are Failing Women with Cancer
A UCL study finds people diagnosed with cancer in English prisons are 28% less likely to receive curative treatment, leading to a 9% higher mortality risk. Women prisoners face compounded barriers, being up to three times less likely to receive...
DOJ Targets NewYork-Presbyterian in Steering Restrictions Antitrust Suit
The U.S. Department of Justice, together with the Southern District of New York, has filed a civil antitrust lawsuit against New York‑Presbyterian Hospital, accusing it of using contract clauses that block insurers from steering patients to lower‑cost providers. The government...
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
Retatrutide, a triple‑agonist peptide, is generating buzz for delivering dramatic weight loss at doses of 8‑12 mg, rivaling semaglutide while causing fewer nausea complaints. Early users note that appetite suppression diminishes after several weeks, yet the drug continues to support weight‑maintenance...
You Are in the 4%
The IRDAI annual report shows only 4% of India’s 1.4 billion population—about 60 million people—carry personal health insurance. Despite rising medical costs, crowdfunding for treatment has surged 2‑2.5 times since 2022, highlighting a financing gap. The author identifies four barriers to coverage: lack...
Imeglimin. A New and Novel Drug Thats Better than Metformin
Imeglimin, a mitochondrial‑targeted antidiabetic agent, is emerging as a novel alternative to metformin. Pre‑clinical studies show it restores mitochondrial function in skeletal muscle and pancreatic β‑cells, enhancing insulin secretion and reducing oxidative stress. Phase‑3 trials report HbA1c reductions of 0.6‑0.9%...
Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
The U.S. Food and Drug Administration has renewed its Modified Risk Tobacco Product (MRTP) authorizations for Philip Morris International’s IQOS heated‑tobacco system and three HEETS consumable flavors. The renewal covers the IQOS 2.4 and IQOS 3.0 devices, allowing PMI to continue marketing...
Blue Cross Blue Shield of Michigan Postpones Modifier 25 Policy in Response to Osteopathic Advocacy
Blue Cross Blue Shield of Michigan announced a postponement of its proposed modifier 25 reimbursement policy after coordinated advocacy from five osteopathic organizations. The delay aims to preserve accurate billing for evaluation and management services, especially osteopathic manipulative treatment, and to...
Links (96)
Recent developments highlight mixed outcomes across health and technology. Monoclonal antibodies targeting amyloid‑beta continue to underperform in Alzheimer trials, while a 13‑week rapamycin study failed to meet its primary endpoints. Meanwhile, AI‑driven writing constitutions sparks debate, meditation research reports a...
What I Wish I Knew About Trying to Get Pregnant
Hannah Bronfman reflects on her trying‑to‑conceive (TTC) journey, revealing that a rare egg‑protein barrier was only identified after IVF, prompting her to wish she’d pursued assisted reproduction sooner. She credits acupuncture for stress relief and implantation support, and emphasizes the...
Agenus Reports Phase II Data Demonstrating Immune Reprogramming and Durable Survival with Botensilimab, Balstilimab and agenT-797 in PD-1 Refractory Gastroesophageal...
Agenus presented Phase II data showing that a combination of botensilimab, balstilimab and the allo‑iNKT cell therapy agenT‑797 achieved a 77% disease‑control rate in PD‑1‑refractory gastroesophageal adenocarcinoma. Patients who received an induction cycle of agenT‑797 before the full regimen experienced median...
![Clinicians Are Failing at Value-Based Care because No One Taught Them the System [PODCAST]](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://kevinmd.com/wp-content/uploads/bd31ce43-6fb7-4665-a30e-ee0a6b592f4c.jpeg)
Clinicians Are Failing at Value-Based Care because No One Taught Them the System [PODCAST]
Clinicians are being asked to deliver value‑based care outcomes without formal training on the underlying metrics or workflow. The shift from fee‑for‑service to outcome‑focused reimbursement places pressure on providers to manage population‑health dashboards and quality scores. Kenneth Botelho, director of...
SAGA Diagnostics to Present New Pathlight™ MRD Data for Ovarian and Metastatic Breast Cancer at AACR 2026
SAGA Diagnostics will present two abstracts at AACR 2026 showcasing its Pathlight™ structural‑variant‑based circulating tumor DNA (ctDNA) assay. In metastatic breast cancer, the test achieved a 77% detection rate, with ultrasensitive reads predicting therapeutic response and preceding radiologic progression. In...
Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer...
Zai Lab reported that its DLL3‑targeting ADC zocilurtatug pelitecan (Zoci) generated a 53.7% confirmed intracranial objective response rate (iORR) in extensive‑stage small‑cell lung cancer (ES‑SCLC) patients with brain metastases, rising to 62.5% at the 1.6 mg/kg dose. In a separate cohort...
If Your Vet Is Recommending the Nobivac NXT Canine Flu Vaccine - Read This!!
A recent FOIA request uncovered 296 adverse event reports linked to Merck's Nobivac NXT canine flu vaccine, the first self‑amplifying RNA vaccine for pets in the United States. The data, covering September 2024 through July 2025, includes deaths, neurological reactions,...